For pharma and medical device partners
Reach the clinicians who are already looking.
Over 400,000 clinicians use Eolas to find the guidance they need for the patient in front of them. We help market access, medical and commercial teams make sure the information those clinicians need is accurate, current and actually there when they search.
Verified health professionals only. Aggregate reporting only. No commercial influence on clinical guidance.
400,000+
registered clinicians
500+
hospital and health system sites
The audience
How Eolas Works.
Eolas is what clinicians open when they need an answer and cannot wait.
Inside the institution
Eolas hosts each organization's own approved guidelines, so it reflects local practice.
Question first
Every session starts with a clinician searching for something specific.
Verified professionals only
Nothing you place is ever visible to the public.
The moment it counts
Built to answer in seconds, on mobile, at the bedside.
Why this is different now
Three things changed at once.
None of them are your fault. All of them are your problem.
The door closed.
Field access to clinicians fell from 60% to 45% in eighteen months (Veeva Pulse, 2024).
The channel moved.
84% of the time physicians spend reading medical content is now digital (M3 Global Research, 2025). Most industry spend still buys advertising slots, not the guidance clinicians actually read.
The search box became an answer box.
The majority of clinicians now turn to AI tools in their day to day clinical practice.
What we do
Four ways to work with us.
Each stands alone. Most partners start with one and add others once the data shows where to go next.
Know what the guidance actually says, everywhere.
Eolas holds the local guidelines and formulary positions in daily use across 500 plus sites. That gives you an accurate, aggregate picture of how national guidance has been translated into local practice.
- Where a national recommendation has been adopted locally, and where it has not
- How pathways vary by region, specialty and site type
- Which guidance is consulted most, and which goes unread
- Movement over time, so adoption is measured rather than guessed
Insight only. It tells you what is happening; it does not let you change it.
Region A adoption
Region B adoption
Region C adoption
Region D adoption
Generative engine optimisation
If the answer does not mention you, you are not in the conversation.
Clinicians increasingly ask a question and read an answer assembled from a handful of sources the model trusts. Your product site is almost never one of them.
51%
of healthcare searches return an AI generated overview (WebFX, 2025)
8% vs 15%
click rate with an AI summary present, versus without (Pew Research Center, 2025)
Top 50
health citation lists contain no pharmaceutical manufacturer domain (BrightEdge, 2026)
50-90%
of AI medical responses are not fully supported by their sources (Wu et al., Nature Communications, 2025)
Why your own site will not fix this.
Answer engines choose sources, not pages, and for health questions they choose government bodies, specialty organizations, journals and clinical reference tools. Regulated promotional copy cannot be written in the citation heavy style they reward, and your most rigorous material sits behind an HCP login no crawler has seen. Schema markup produced no measurable uplift across 1,885 pages, and Google has said it will not use llms.txt (Ahrefs, 2026; Google Search Central, 2025).
What actually moves the needle.
The founding academic work tested nine tactics across 10,000 queries. The winners were direct quotations, specific figures and authoritative citations; keyword stuffing made things worse. The gain is largest for sources that are not already dominant, raising visibility by 115% for a source ranked fifth (Aggarwal et al., KDD 2024). That is a description of Eolas.
AI Visibility, from Eolas
Eolas content is structured, cited and guideline anchored, which is the profile answer engines select for. We give partners a structured way to make sure the reference information clinicians need about your portfolio is discoverable, accurate and current.
Baseline visibility audit
How your portfolio is represented today when clinicians ask real questions of the major answer engines.
Content structuring
We work with your medical team to shape reference information into the citable format these systems select for.
Presence in a cited source
That material sits on Eolas, clearly attributed to you, in a source already treated as authoritative.
Ongoing tracking
Quarterly reporting on how your portfolio appears in AI answers, and what changed.
We will not claim to control what a third party model says. We make sure accurate, attributed information exists in a source those models rely on, and show you the difference it makes.
How it works
First conversation to first report, typically eight to twelve weeks.
- 1
Define the clinical need
We start with the clinical question. If we cannot articulate a genuine clinical benefit, we will not take the project.
- 2
Build and certify
Your medical team and ours structure the material. Your signatory certifies it. You get a locked preview with version control.
- 3
Go live
Live on Eolas, clearly attributed to you, separate from clinical guidance, for verified health professionals only.
- 4
Measure and iterate
Aggregate reporting on reach and engagement, plus the search insight that shows the next gap. Quarterly review.
Who we work with
Different teams, different question.
Answer the questions your field team never hears.
Field medical reaches a small number of clinicians very well. Eolas reaches the rest, at the moment they have a question, and shows in aggregate where uncertainty about your therapy area sits. Medical information investment fell from 14% to 11% of medical affairs budgets between 2024 and 2025 while clinician demand did not (ZS Medical Affairs Outlook, 2025).
Engagement models
Three ways to start.
Pricing depends on scope, therapy area and market. You get a firm number after the first conversation.
Insight
Aggregate search and guideline intelligence for your therapy area, reported quarterly. No content placement.
Presence
A clearly attributed space for your clinical reference material, guideline update alerts where relevant, and aggregate engagement reporting.
AI Visibility
Baseline audit, content structuring with your medical team, presence in a cited clinical source and quarterly tracking. Standalone or added to either model.
Start with the clinical question.
Tell us the therapy area and the clinicians you want to reach. We will tell you honestly whether there is something worth doing. Thirty minutes.
- Verified health professionals only
- Aggregate reporting only
- No commercial influence on clinical guidance
Request a conversation
Book a 30 minute discovery call, or ask for a baseline AI visibility audit for your portfolio.